Results 31 to 40 of about 274,722 (228)
Epicutaneous immunotherapy induces gastrointestinal LAP+ regulatory T cells and prevents food-induced anaphylaxis. [PDF]
J Allergy Clin Immunol, 2017 Tordesillas L +5 more
europepmc +2 more sources
Iranian Journal of Allergy, Asthma and Immunology, 2022 Allergen-specific immunotherapy (AIT) involves administering allergen extracts. It is used to desensitize allergic patients. Herbal allergen extracts that are optimum in efficacy and fewest in side effects are still challenging to produce.
Soheila Asoudeh Moghanloo +4 more
doaj +1 more source
Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysis [PDF]
, 2017 Background: The European Academy of Allergy and Clinical Immunology (EAACI) is developing Guidelines for Allergen Immunotherapy (AIT) for IgE-mediated Food Allergy.
Dhami, Sangeeta +2 more
core +9 more sources
Insights Into Complex Murine Models of Allergy and Anaphylaxis: The Central Role of IgE and Mast Cells in Advancing Human Therapies. [PDF]
Eur J ImmunolMurine allergy model outcomes differ by sensitization route, allergen type, and mouse strain, influencing mechanisms such as IgE and mast cell involvement and the therapeutic relevance of each model. Understanding how experimental parameters shape outcomes is essential for selecting appropriate models and effectively translating findings to clinical ...
Nagata Y, Suzuki R.
europepmc +2 more sources
A practical view of immunotherapy for food allergy [PDF]
Korean Journal of Pediatrics, 2016 Food allergy is common and sometimes life threatening for Korean children. The current standard treatment of allergen avoidance and self-injectable epinephrine does not change the natural course of food allergy.
Tae Won Song
doaj +1 more source
Oral Immunotherapy for Children with Cow’s Milk Allergy
Pathogens, 2021 Cow’s milk allergy (CMA) is one of the most common IgE-dependent food allergies in children. Some children develop severe and persistent CMA, with near-fatal reactions after exposure to trace amounts of cow’s milk (CM).
Mika Ogata, Jun Kido, Kimitoshi Nakamura
doaj +1 more source
Positive and negative AIT trials: What makes the difference? [PDF]
, 2018 Background: Allergen immunotherapy has proven to be efficacious in allergic rhinitis and asthma. However, results from randomised clinical trials may vary substantially. Clinical trials may unexpectedly fail.
Gerth van Wijk, R. (Roy)
core +6 more sources
World Allergy Organization Journal, 2022 Background: The prevalence of cow's milk allergy (CMA) is approximately 2–4.5% in infants and less than 0.5% in adults. Most children outgrow cow's milk allergy in early childhood, particularly that to the baked milk products. Immunotherapy with unheated
Jan L. Brozek +37 more
doaj +1 more source
The future outlook on allergen immunotherapy in children: 2018 and beyond. [PDF]
, 2018 Allergen immunotherapy (AIT) is the only currently available immune-modifying and aetiological treatment for patients suffering from IgE-mediated diseases.
Arasi S, Corsello G, Pajno GB, Villani A
core +2 more sources
Immune response evolution in peanut epicutaneous immunotherapy for peanut‐allergic children
Allergy. European Journal of Allergy and Clinical Immunology, 2023 Epicutaneous immunotherapy with investigational Viaskin™ Peanut 250 μg (DBV712) has demonstrated statistically superior desensitization versus placebo in peanut‐allergic children in clinical trials.
Marie Bastin +10 more
semanticscholar +1 more source